Pulsatile LH secretion and ovarian follicular wave emergence and growth in anestrous ewes.
The objective of this study was to determine if pulsatile LH secretion was needed for ovarian follicular wave emergence and growth in the anestrous ewe. In Experiment 1, ewes were either large or small (10 x 0.47 or 5 x 0.47 cm, respectively; n = 5/group) sc implants releasing estradiol-17 beta for 10 d (Day 0 = day of implant insertion), to suppress pulsed LH secretion, but not FSH secretion. Five sham-operated control ewes received no implants. In Experiment 2, 12 ewes received large estradiol-releasing implants for 12 d (Day 0 = day of implant insertion); six were given GnRH (200 ng IV) every 4 h for the last 6 d that the implants were in place (to reinitiate pulsed LH secretion) whereas six Control ewes were given saline. Ovarian ultrasonography and blood sampling were done daily; blood samples were also taken every 12 min for 6 h on Days 5 and 9, and on Days 6 and 12 of the treatment period in Experiments 1 and 2, respectively. Treatment with estradiol blocked pulsatile LH secretion (P < 0.001). In Experiment 1, implant treatment halted follicular wave emergence between Days 2 and 10. In Experiment 2, follicular waves were suppressed during treatment with estradiol, but resumed following GnRH treatment. In both experiments, the range of peaks in serum FSH concentrations that preceded and triggered follicular wave emergence was almost the same as control ewes and those given estradiol implants alone or with GnRH; mean concentrations did not differ (P < 0.05). We concluded that some level of pulsatile LH secretion was required for the emergence of follicular waves that were triggered by peaks in serum FSH concentrations in the anestrous ewe.
Seekallu
Srinivas V
SV
Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Barrett
David M W
DM
Toosi
Behzad M
BM
Clarke
Kelsey
K
Ewen
Kirk A
KA
Duggavathi
Rajesha
R
Davies
Kate L
KL
Pattullo
Kim M
KM
Bagu
Edward T
ET
Rawlings
Norman C
NC
D000465:Algorithms; D000780:Anestrus / Q000097:blood / Q000378:metabolism / Q000502:physiology; D000818:Animals; D048429:Cell Size / Q000187:drug effects; D003338:Corpus Luteum / Q000187:drug effects / Q000378:metabolism; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D055104:Infusions, Subcutaneous; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D006080:Ovarian Follicle / Q000166:cytology / Q000254:growth & development* / Q000502:physiology*; D010060:Ovulation / Q000097:blood / Q000187:drug effects; D011673:Pulsatile Flow; D012756:Sheep / Q000097:blood / Q000378:metabolism* / Q000502:physiology*
D004343:Drug Implants; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone